Psychotropic drug use by mentally retarded persons with behavioural problems residing in care homes;Het psychofarmacagebruik door verstandelijk gehandicapte bewoners van gezinsvervangende tehuizen

Tijdschrift voor Psychiatrie

Volumn 45, Issue 11, 2003, Pages 667-676

  Stolker, J J ^a,c   Koedoot, P J ^b   Heerdink, E R ^a   Leufkens, H G M ^a   Nolen, W A ^d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^c Altrecht Geestelijke Gezondheidszorg   (Netherlands)

^d NONE

Author keywords

Group homes; Mental disorders; Mental retardation; Psychotropic drugs

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALADJUSTMENT; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; NURSING HOME; NURSING STAFF; PRESCRIPTION; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RESIDENTIAL CARE; SAMPLING; SCREENING;

EID: 0242473142     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Aman, M.G., Sarphare, G., & Burrow, W.H. (1995). Psychotropic drugs in group homes: prevalence and relation to demographic/ psychiatric variables. American Journal on Mental Retardation, 99, 500-509.
2. Balboni, G., Battagliese, G., & Pedrabissi, L. (2000). The psychopathology inventory for mentally retarded adults: factor structure and comparisons between subjects with or without dual diagnosis. Research in Developmental Disabilities, 21, 311-321.
3. Bates, W.J., Smeltzer, D.J., & Arnoczky, S.M. (1986). Appropriate and inappropriate use of psychotherapeutic medications for institutionalized mentally retarded persons. American Journal of Mental Deficiency, 90, 363-370.
4. Baumeister, A.A., Sevin, J.A., & King, B.H. (1998). Neuroleptic medications. In M.G. Aman & S. Reiss (Red.), Psychotropic medications and developmental disabilities. The international consensus handbook (pp. 133-150). Columbus, OH: Ohio State University.
5. Borthwick-Duffy, S.A. (1994). Epidemiology and prevalence of psychopathology in people with mental retardation. Journal of Consulting and Clinical Psychology, 62, 17-27.
6. Clarke, D. (1997). Physical treatments. In S.G. Read (Red.), Psychiatry in learning disability (pp. 350-379). London: W.B. Saunders Company.
7. Davidson, J.R., & Meltzer-Brody, S.E. (1999). The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? The Journal of Clinical Psychiatry, 60(Suppl. 7), 4-9.
8. Hirschfeld, R.M., Keller, M.B., Panico, S., e.a. (1997). The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. The Journal of the American Medical Association, 277, 333-340.
9. Johns, M.R., & McDaniel, W.F. (1998). Areas of convergence and discordance between the MMPI-168 and the Reiss Screen for Maladaptive Behavior in mentally retarded clients. Journal of Clinical Psychology, 54, 529-535.
10. Kiernan, C., Reeves, D., & Alborz, A. (1995). The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour. Journal of Intellectual Disability Research, 39, 263-274.
11. Koedoot, P., & Kok, I. (1996). Gedragsproblematiek in GVT'S: de omvang en aanpak van gedragsproblemen in semi-murale woonvoorzieningen voor verstandelijk gehandicapten. Utrecht: Nederlands Centrum Geestelijke Volksgezondheid.
12. Landelijke Registratie Zorg-en dienstsverlening aan mensen met een verstandelijke handicap. (1998). Landeijke tabellen intramuraal 1996. Gebruikers geïnventariseerd 1995 en 1996. Inventarisatie bewoners en deelnemers semimurale voorzieningen voor mensen met een vetstandelijke handicap. Utrecht: Vereniging Gehandicaptenzorg Nederland.
13. Malt, U.F., Nystad, R., Bache, T., e.a. (1995). Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients. British Journal of Psychiatry, 166, 374-377.
14. Matson, J.L., van Minnen, A., & Hoogduin, K. (1994). Handleiding: de Nederlandse vetsie van de Psychopathology Inventory for Mentally Retarded Adults. Worthington, Ohio: IDS.
15. Minnen, A. van. (1995). Een verschil van dag en nacht? De vergelijking van ambulante en klinische behandeling van sterk gedragsgestoorde licht verstandelijk gehandicapten (SGLVG). Venray: Nieuw Spraeland.
16. Minnen, A. van, Savelsberg, P.M., & Hoogduin K.A. (1994). A Dutch version of the Psychopathology Inventory for Mentally Retarded Adults (PIMRA). Research in Developmental Disabilities, 15, 269-278.
17. Minnen, A. van, Savelsberg, P.M., & Hoogduin, K. A. (1995). A Dutch version of the Reiss Screen of Maladaptive Behavior. Research in Developmental Disabilities, 16, 43-49.
18. Nordic Council on Medicines. (1995). Guidelines for DDD. Oslo: WHO collaborating Centre for Drug Statistics and Methodology.
19. Reiss, S. (1988). The Reiss Screenfor Maladaptive Behavior test manual. Worthington, Ohio: IDS Publishing.
20. Reiss, S., van Minnen, A., & Hoogduin, K. (1994). Handleiding: de Nederlandse versie van de Reiss Screen for Maladaptive Behavior. Worthington, Ohio: IDS.
21. Rinck, C. (1998). Epidemiology and psychoactive medication. In M.G. Aman & S. Reiss (Red.), Psychotropic medications and developmental disabilities. The international consensus handbook (pp. 31-44). Columbus, OH: Ohio State University.
22. Schroijenstein Lantman-de Valk, H.M. van, Kessel, A.G., Haveman M.J., e.a. (1995). Medicijngebruik door verstanlijk gehandicapten in instituten en gezinsvervangende tehuizen. Nederlands Tijdschrift voor Geneeskunde, 139, 1083-1088.
23. Senatore, V., Matson, J.L., & Kazdin, A.E. (1985). An inventory to assess psychopathology of mentally retarded adults. American Journal of Mental Deficiency, 89, 459-466.
24. Singh, N.N., Ellis, C.R., & Wechsler, H. (1997). Psychopharmacoepidemiology of mental retardation: 1966 to 1995. Journal Child and Adolescent Psychopharmacology, 7, 255-266.
25. Sovner, R., Pary, R.J., Dosen, A., e.a. (1998). Antidepressants. In M.G. Aman & S. Reiss (Red.), Psychotropic medica ions and developmental disabilities. The international consensus handbook (pp. 179-200). Columbus, OH: Ohio State University.
26. Spreat, S., Conroy, J.W., & Jones, J.C. (1997). Use of psychotropic medication in Oklahoma: a statewide survey. American Journal on Mental Retardation, 102, 80-85.
27. Stone, RK., Alvarez, W.F., Ellman, G., e.a. (1989). Prevalence and prediction of psychotropic drug use in California developmental centers. American Journal on Mental Retardation, 93, 627-632.
28. Sturmey, P., & Bertman, L.J. (1994). Validity of the Reiss Screen for Maladaptive Behavior. American Journal on Mental Retardation, 99, 201-206.
29. Szymanski, L.S. (1994). Mental retardation and mental health: concepts, aetiology and incidence. In N. Bouras (Red.), Mental health in mental retardation: recent advances and practices (pp. 19-33). Cambridge, England: Cambridge University Press.
30. Tuinier, S., & Verhoeven, W.M.A. (1994). Pharmacological advances in mental retardation: a need for reconceptualization. Current Opinion in Psychiatry, 7, 380-386.
31. Verhoeven, W.M.A., & Tuinier, S. (1999a). Farmacotherapie bij verstandelijk gehandicapten met gedragsstoornissen en/of psychiatrische aandoeningen; een dimensionele benadering. Tijdschrift voor Psychiatrie, 41, 219-231.
32. Verhoeven, W.M.A., & Tuinier, S. (1999b). Neuropsychiatrische diagnostiek. In W.M.A. Verhoeven, S. Tuinier, & L.M.G. Curfs (Red.), Diagnostiek en behandeling van gedragsproblemen bij verstandlijk gehandicapten (pp. 35-46). Houten/Diegem: Bohn Stafleu Van Loghum.
33. Waarde, J.A. van, Stolker, J.J., & Van, H.L. (1999). Gedragsveranderingen bij mensen met een verstandelijke handicap begrepen en behandeld door consultatieve psychiatrie. Nederlands Tijdschrift voor Geneeskunde, 143, 1801-1804.
34. Werry, J.S. (1998). Anxiolytics and sedatives. In M.G. Aman & S. Reiss (Red.), Psychotropic medications and developmental disabilities. The international consensus handbook (pp. 201-214). Columbus, OH: Ohio State University.